Exscientia’s $60 Million Series C Financing Round

Paolo Bossi

Latham & Watkins advised Exscientia on the deal, while Goodwin Procter LLP advised Novo Holdings. Exscientia, the world leading artificial intelligence (AI) drug company, raised $60…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

…

This content is for Standard 1 Year members only.
Login Join Now